DK0448765T3 - Use of guanidine derivatives for the preparation of a drug with NPY antagonistic effect - Google Patents

Use of guanidine derivatives for the preparation of a drug with NPY antagonistic effect

Info

Publication number
DK0448765T3
DK0448765T3 DK90106200.0T DK90106200T DK0448765T3 DK 0448765 T3 DK0448765 T3 DK 0448765T3 DK 90106200 T DK90106200 T DK 90106200T DK 0448765 T3 DK0448765 T3 DK 0448765T3
Authority
DK
Denmark
Prior art keywords
drug
preparation
guanidine derivatives
antagonistic effect
npy antagonistic
Prior art date
Application number
DK90106200.0T
Other languages
Danish (da)
Inventor
Kurt-Henning Dr Ahrens
Martin C Dr Michel
Johann Peter Dr Dipl Moersdorf
Helmut Dr Dipl-Ch Schickaneder
Heidrun Dr Engler
Original Assignee
Heumann Pharma Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heumann Pharma Gmbh & Co filed Critical Heumann Pharma Gmbh & Co
Application granted granted Critical
Publication of DK0448765T3 publication Critical patent/DK0448765T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The use of guanidine derivatives with the basic framework <IMAGE> for the manufacture of a medicament with NPY-antagonistic activity and, in particular, for the manufacture of a medicament for the treatment of high blood pressure is described.
DK90106200.0T 1990-03-30 1990-03-30 Use of guanidine derivatives for the preparation of a drug with NPY antagonistic effect DK0448765T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90106200A EP0448765B1 (en) 1990-03-30 1990-03-30 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity

Publications (1)

Publication Number Publication Date
DK0448765T3 true DK0448765T3 (en) 1994-09-19

Family

ID=8203843

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90106200.0T DK0448765T3 (en) 1990-03-30 1990-03-30 Use of guanidine derivatives for the preparation of a drug with NPY antagonistic effect

Country Status (14)

Country Link
EP (1) EP0448765B1 (en)
JP (1) JPH0789939A (en)
KR (1) KR910016329A (en)
AT (1) ATE109979T1 (en)
AU (1) AU637882B2 (en)
CA (1) CA2037433A1 (en)
DE (1) DE59006842D1 (en)
DK (1) DK0448765T3 (en)
ES (1) ES2058651T3 (en)
HU (1) HU207945B (en)
IE (1) IE65252B1 (en)
IL (1) IL97424A (en)
PT (1) PT97138A (en)
ZA (1) ZA911471B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993012139A1 (en) * 1991-12-19 1993-06-24 Garvan Institute Of Medical Research A novel molecule which inhibits neuropeptide tyrosine biological function
US5516653A (en) * 1993-12-28 1996-05-14 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
US5545549A (en) * 1994-02-03 1996-08-13 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
US5989920A (en) * 1994-12-02 1999-11-23 Synaptic Pharmaceutical Corporation Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5
US5602024A (en) 1994-12-02 1997-02-11 Synaptic Pharmaceutical Corporation DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof
AU7692996A (en) * 1995-12-01 1997-06-27 Ciba-Geigy Ag Receptor antagonists
WO1997020822A1 (en) * 1995-12-01 1997-06-12 Novartis Ag Quinazolin-2,4-diazirines as npy receptor antagonist
AU2764797A (en) * 1996-05-14 1997-12-05 Novo Nordisk A/S Somatostatin agonists and antagonists
WO1998007420A1 (en) * 1996-08-23 1998-02-26 Agouron Acquisition Corp. Neuropeptide-y ligands
FR2754709B1 (en) 1996-10-23 1999-03-05 Sanofi Sa COSMETIC COMPOSITION CONTAINING AN ANTAGONIST OF GAMMA NEUROPEPTIDE RECEPTORS AND ALPHA 2 ANTAGONISTS THAT MAY BE INCORPORATED IN SUCH A COMPOSITION
JP2001502712A (en) * 1996-10-31 2001-02-27 ノボ ノルディスク アクティーゼルスカブ Bound somatostatin agonists and antagonists
US6048900A (en) 1998-02-13 2000-04-11 Bayer Corporation Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists
US6245817B1 (en) 1997-02-14 2001-06-12 Bayer Corporation NPY5 receptor antagonists and methods for using same
AU6267198A (en) * 1997-02-14 1998-09-08 Bayer Corporation Amides as npy5 receptor antagonists
WO1998035957A1 (en) * 1997-02-14 1998-08-20 Bayer Corporation Amide derivatives as selective neuropeptide y receptor antagonists
US6713265B1 (en) 1997-06-04 2004-03-30 Synaptic Pharmaceutical Corporation Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
US6121260A (en) 1997-07-03 2000-09-19 Neurogen Corporation Method of treating conditions susceptible to modulation of NPY receptors with diarylimidazole derivatives
ES2161594B1 (en) * 1998-12-17 2003-04-01 Servier Lab NEW DERIVATIVES OF HYDRAZIDE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
AU2935200A (en) 1999-04-30 2000-11-17 Pfizer Products Inc. Compounds for the treatment of obesity
WO2002024657A2 (en) 2000-09-20 2002-03-28 Schering Corporation Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
WO2002044141A2 (en) 2000-09-20 2002-06-06 Schering Corporation Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
MXPA03002448A (en) 2000-09-20 2003-06-19 Schering Corp Substituted imidazoles as dual histamine h1 and h3 agonists or antgonists.
MY129677A (en) 2000-09-20 2007-04-30 Schering Corp Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199845B1 (en) * 1985-04-02 1990-08-01 HEUMANN PHARMA GMBH &amp; CO Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them
DE3631334A1 (en) * 1986-09-15 1988-03-17 Heumann Pharma Gmbh & Co NEW IMIDAZOLYLGUANIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS

Also Published As

Publication number Publication date
IE65252B1 (en) 1995-10-18
ES2058651T3 (en) 1994-11-01
JPH0789939A (en) 1995-04-04
CA2037433A1 (en) 1991-10-01
IE910995A1 (en) 1991-10-09
AU7206891A (en) 1991-10-03
KR910016329A (en) 1991-11-05
ATE109979T1 (en) 1994-09-15
HUT57044A (en) 1991-11-28
IL97424A0 (en) 1992-06-21
IL97424A (en) 1995-05-26
ZA911471B (en) 1991-11-27
DE59006842D1 (en) 1994-09-22
PT97138A (en) 1991-11-29
AU637882B2 (en) 1993-06-10
HU207945B (en) 1993-07-28
HU910979D0 (en) 1991-10-28
EP0448765B1 (en) 1994-08-17
EP0448765A1 (en) 1991-10-02

Similar Documents

Publication Publication Date Title
ES2058651T3 (en) USE OF GUANIDINE DERIVATIVES FOR THE MANUFACTURE OF A MEDICINE WITH ANTAGONIST ACTIVITY OF NPY.
EA200101156A1 (en) DRUG COMPOSITIONS OF A NEW TYPE ON THE BASIS OF POSSESSING HOLYNTHERGIC ACTION OF COMPOUNDS AND β-MIMETIC
TR200001891T2 (en) ASPB28- Human insulin and its use.
IT219694Z2 (en) DISPOSABLE SYRINGE, DISPOSABLE
SE8804629D0 (en) NEW THERAPEUTICALLY ACTIVE COMPOUNDS
AU2506388A (en) Azelastine-containing medicaments for application in the nose and/or at the eye
NO870241L (en) HYPOGLYCHEMICAL TIAZOLIDE INDIA.
DE69011059D1 (en) Heterocyclic acylaminothiazole derivatives, their preparation and pharmaceutical preparations containing them.
GEP19981482B (en) Use of 1,3 - Oxatiolan Nucleozides Analoges for Treatment of Hepatitis B
DK373187D0 (en) MEDICINAL WITH SLOW RELEASE OF THE ACTIVE INGREDIENT
DK261490D0 (en) NEW PHARMACEUTICAL COMPOUND
FI922983A7 (en) Pyrimidine-4-carboxamide derivatives, their preparation and therapeutic use
FI914611A7 (en) 2-Aminopyrimidine-4-carboxamide derivatives, their preparation and therapeutic use
FI913034A0 (en) FOERENING MED MAGSYRAINHIBERANDE EFFEKT OCH FOERFARANDE FOER DESS FRAMSTAELLNING.
SE8400723D0 (en) PHARMACEUTICAL COMPOSITION
DK0476113T3 (en) Drug for the treatment of hyperlipidemia and / or atherosclerosis
DE59102245D1 (en) N-phenyl-piperidyl-4-amines and medicaments containing them.
DE3877365D1 (en) MEDICINE WITH METHYLCELLULOSE.
ATE44875T1 (en) 4-AMINO-2-(IMIDAZOLIDIN-2-ON-L-YL)-PYRIMIDIN-5CARBONS|URE-(N-(3-TRIFLUORMETHYL-PHENYL)-AMIDE) FOR ANTITHROMBOTIC PROPHYLAXIS AND TREATMENT AND ITS USE FOR THE PREPARATION OF ANTITHROMBOTIC ACTIVE AGENTS MEDICATIONS.
NO307126B1 (en) Use of biologically active ureido derivatives for the manufacture of a medicament for use in the treatment of lentivirus-induced disease
SE9602262D0 (en) New use of cystine derivatives
NO890997D0 (en) APPLICATOR FOR SKIN CARE, SKIN CARE AND MEDICAL SALVATION.
IT1153183B (en) PHARMACEUTICAL FOMULATIONS INCLUDING HUMAN INSULIN, C-PEPTIDE AND PRO-INSULIN
SE9101341D0 (en) NEW MEDICINAL USE
DE3781357D1 (en) 5-FLUOROURACIL DERIVATIVES, PHARMACEUTICAL PREPARATION AND USE.